AIMC Topic: Neoplasms

Clear Filters Showing 2161 to 2170 of 2356 articles

Artificial Intelligence in Cancer Research and Precision Medicine.

Cancer discovery
Artificial intelligence (AI) is rapidly reshaping cancer research and personalized clinical care. Availability of high-dimensionality datasets coupled with advances in high-performance computing, as well as innovative deep learning architectures, has...

A novel machine learning approach (svmSomatic) to distinguish somatic and germline mutations using next-generation sequencing data.

Zoological research
Somatic mutations are a large category of genetic variations, which play an essential role in tumorigenesis. Detection of somatic single nucleotide variants (SNVs) could facilitate downstream analysis of tumorigenesis. Many computational methods have...

A comparison of general and disease-specific machine learning models for the prediction of unplanned hospital readmissions.

Journal of the American Medical Informatics Association : JAMIA
Unplanned hospital readmissions are a burden to patients and increase healthcare costs. A wide variety of machine learning (ML) models have been suggested to predict unplanned hospital readmissions. These ML models were often specifically trained on ...

Development of a "meta-model" to address missing data, predict patient-specific cancer survival and provide a foundation for clinical decision support.

Journal of the American Medical Informatics Association : JAMIA
OBJECTIVE: Like most real-world data, electronic health record (EHR)-derived data from oncology patients typically exhibits wide interpatient variability in terms of available data elements. This interpatient variability leads to missing data and can...

canSAR: update to the cancer translational research and drug discovery knowledgebase.

Nucleic acids research
canSAR (http://cansar.icr.ac.uk) is the largest, public, freely available, integrative translational research and drug discovery knowledgebase for oncology. canSAR integrates vast multidisciplinary data from across genomic, protein, pharmacological, ...

Open Targets Platform: supporting systematic drug-target identification and prioritisation.

Nucleic acids research
The Open Targets Platform (https://www.targetvalidation.org/) provides users with a queryable knowledgebase and user interface to aid systematic target identification and prioritisation for drug discovery based upon underlying evidence. It is publicl...

Deep learning for in vivo near-infrared imaging.

Proceedings of the National Academy of Sciences of the United States of America
Detecting fluorescence in the second near-infrared window (NIR-II) up to ∼1,700 nm has emerged as a novel in vivo imaging modality with high spatial and temporal resolution through millimeter tissue depths. Imaging in the NIR-IIb window (1,500-1,700 ...

Artificial intelligence in cancer diagnostics and therapy: current perspectives.

Indian journal of cancer
Artificial intelligence (AI) has found its way into every sphere of human life including the field of medicine. Detection of cancer might be AI's most altruistic and convoluted challenge to date in the field of medicine. Embedding AI into various asp...

Monte Carlo Dose Calculation Using MRI Based Synthetic CT Generated by Fully Convolutional Neural Network for Gamma Knife Radiosurgery.

Technology in cancer research & treatment
The aim of this work is to study the dosimetric effect from generated synthetic computed tomography (sCT) from magnetic resonance (MR) images using a deep learning algorithm for Gamma Knife (GK) stereotactic radiosurgery (SRS). The Monte Carlo (MC) m...